top of page

New Report Reveals Opportunities to Improve Cancer Diagnosis – The Most Inefficient Area of Cancer Care in Canada

Cancer is the leading cause of death in Canada. Due to missed diagnoses during the pandemic, we are now facing an echo pandemic in cancer.  Before the pandemic, it was already estimated that 2 in 5 Canadians (40%) would get cancer in their lifetime and 1 in 4 (25%) would die from their disease. With COVID-19, things have just become worse. Alberta, British Columbia, and Quebec reported a 20-23% drop in cancer diagnoses from June – September 2020. It is predicted that cancer care disruptions during the pandemic could lead to 21,247 more cancer deaths in Canada over the next decade. The represents 355,173 years of lost life expected due to pandemic-related diagnostic and treatment delays.

All.Can Canada has launched a new report titled Optimizing Diagnosis in Canadian Cancer Care, which reveals findings from a comprehensive research project including a literature review, interviews with patients and caregivers, and a survey of healthcare providers across Canada.

 

“If you don’t get a swift diagnosis and enter into cancer care in a timely fashion, treatment can’t start. We need to listen to what cancer patients say would improve their experience of diagnosis,” says Kathy Barnard, who is a stage IV melanoma survivor, Founder of Save Your Skin Foundation, and a member of All.Can Canada’s steering committee. “People are cycling around trying to get their symptoms investigated for months, sometimes years. This was already happening before COVID-19 and now things are worse. Ignoring the findings of this report would be a missed opportunity to do the right thing by people who desperately need cancer care and make changes that would make a real difference.”

All.Can Canada’s report reveals the labyrinth most people experience when trying to diagnose a suspicion of cancer. From the moment a person tries to interact with a healthcare provider over a suspicion of cancer to the point they receive their

diagnosis, seven outcomes were identified as critical to a quality diagnosis experience:

 

1) Swiftness of the diagnosis process;

2) Validation of concerns by primary care providers;

3) Excellent patient-provider communication;

4) Effective provider-provider communication;

5) Better information;

6) Integrated psychosocial support; and

7) Coordinated and managed care.

February 17, 2022 

2 min read

Led by patient groups and people with lived experiences of cancer, AllCan Canada is a national, multi-stakeholder platform fo

All.Can Canada is a patient-led, multi-stakeholder initiative committed to ensuring swift, accurate, and appropriately delivered diagnosis of cancer in Canada.

 

Find out more about patient-reported inefficiencies and opportunities for improvement in All.Can Canada’s new report.

 

Download the full report: Optimizing Diagnosis in Canadian Cancer Care

Or download the summary: Optimizing Diagnosis Executive Summary

Patient and Nurse

Led by patient groups and those with lived cancer experience, All.Can Canada is a national platform focused on improving cancer diagnosis. It aims to streamline access to timely, accurate, and appropriately delivered diagnoses. All.Can Canada engages government stakeholders, health authorities, healthcare providers, and patient organizations to share key findings and resources with the diagnosis ecosystem to improve patient outcomes.

Led by patient groups and people with lived experiences of cancer, AllCan Canada is a national, multi-stakeholder platform fo

Sign up for our newsletter.

  • Facebook
  • LinledIn
  • YouTube

The head office of Save Your Skin Foundation, the Secretariat of All.Can Canada, is located on the traditional unceded territory of the Syilx Okanagan Nation. The Save Your Skin Foundation and All.Can Canada staff, board, and community are grateful to the Okanagan people, who are the stewards of these beautiful lands.

 

All.Can Canada is an initiative of Save Your Skin Foundation, a not-for-profit organisation registered in Canada. Its work is made possible with financial support from Bristol Myers Squibb, Merck, Novartis, Pfizer, Johnson & Johnson, AstraZeneca, Amgen, and Medison.

Charitable Reg. #857756589R

bottom of page